ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 129 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $10,711,000 | +110.1% | 115,252 | +34.6% | 0.00% | 0.0% |
| Q3 2021 | $5,097,000 | -2.2% | 85,599 | +12.0% | 0.00% | 0.0% |
| Q2 2021 | $5,209,000 | -15.4% | 76,404 | -13.9% | 0.00% | 0.0% |
| Q1 2021 | $6,160,000 | +21.4% | 88,782 | +34.4% | 0.00% | 0.0% |
| Q4 2020 | $5,074,000 | -21.7% | 66,057 | -23.7% | 0.00% | 0.0% |
| Q3 2020 | $6,479,000 | +19.9% | 86,624 | +0.9% | 0.00% | 0.0% |
| Q2 2020 | $5,405,000 | +73.5% | 85,856 | +15.7% | 0.00% | 0.0% |
| Q1 2020 | $3,115,000 | -83.9% | 74,192 | -82.5% | 0.00% | -50.0% |
| Q4 2019 | $19,304,000 | +310.2% | 425,011 | +313.2% | 0.00% | +100.0% |
| Q3 2019 | $4,706,000 | -57.7% | 102,853 | -45.8% | 0.00% | -50.0% |
| Q2 2019 | $11,127,000 | +69.9% | 189,778 | +29.9% | 0.00% | +100.0% |
| Q1 2019 | $6,550,000 | +687.3% | 146,115 | +584.2% | 0.00% | – |
| Q4 2018 | $832,000 | -32.2% | 21,356 | -20.0% | 0.00% | – |
| Q3 2018 | $1,228,000 | -78.2% | 26,687 | -79.4% | 0.00% | -100.0% |
| Q2 2018 | $5,644,000 | +85.5% | 129,451 | +68.1% | 0.00% | – |
| Q1 2018 | $3,043,000 | +658.9% | 77,021 | +552.2% | 0.00% | – |
| Q4 2017 | $401,000 | +21.9% | 11,809 | -8.4% | 0.00% | – |
| Q3 2017 | $329,000 | +161.1% | 12,894 | +72.2% | 0.00% | – |
| Q2 2017 | $126,000 | – | 7,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |